Dolphin
Senior Member (Voting Rights)
Free full text:
https://www.sciencedirect.com/science/article/pii/S2049080121010955
Review
Can l-carnitine reduce post-COVID-19 fatigue?
RoyaVaziri-harami a ParisaDelkash b
https://doi.org/10.1016/j.amsu.2021.103145Get rights and content
Highlights
•
The coronavirus disease is a viral infection that could induce different respiratory.
•
A significant number of patients infected with the new coronavirus suffer from chronic fatigue.
•
Clinical trials have shown the effectiveness of L-carnitine in relieving fatigue.
Abstract
A significant number of patients infected with the new coronavirus suffer from chronic fatigue syndrome after COVID-19, and their symptoms may persist for months after the infection. Nevertheless, no particular treatment for post-disease fatigue has been found. At the same time, many clinical trials have shown the effectiveness of l-carnitine in relieving fatigue caused by the treatment of diseases such as cancer, MS, and many other diseases. Therefore, it can be considered as a potential option to eliminate the effects of fatigue caused by COVID-19, and its consumption is recommended in future clinical trials to evaluate its effectiveness and safety.
CFS
Chronic fatigue syndrome
PVN
paraventricular nucleus
ACE2
angiotensin-converting enzyme 2
RAS
renin-angiotensin system
IL
interleukin
Keywords
COVID-19
Fatigue
l-carnitine
Coronavirus
https://www.sciencedirect.com/science/article/pii/S2049080121010955
Review
Can l-carnitine reduce post-COVID-19 fatigue?
RoyaVaziri-harami a ParisaDelkash b
https://doi.org/10.1016/j.amsu.2021.103145Get rights and content
Highlights
•
The coronavirus disease is a viral infection that could induce different respiratory.
•
A significant number of patients infected with the new coronavirus suffer from chronic fatigue.
•
Clinical trials have shown the effectiveness of L-carnitine in relieving fatigue.
Abstract
A significant number of patients infected with the new coronavirus suffer from chronic fatigue syndrome after COVID-19, and their symptoms may persist for months after the infection. Nevertheless, no particular treatment for post-disease fatigue has been found. At the same time, many clinical trials have shown the effectiveness of l-carnitine in relieving fatigue caused by the treatment of diseases such as cancer, MS, and many other diseases. Therefore, it can be considered as a potential option to eliminate the effects of fatigue caused by COVID-19, and its consumption is recommended in future clinical trials to evaluate its effectiveness and safety.
CFS
Chronic fatigue syndrome
PVN
paraventricular nucleus
ACE2
angiotensin-converting enzyme 2
RAS
renin-angiotensin system
IL
interleukin
Keywords
COVID-19
Fatigue
l-carnitine
Coronavirus